href="https://fonts.googleapis.com/css2?family=Work+Sans:ital,wght@0,200;0,300;0,400;0,500;0,600;0,700;1,200;1,300;1,400;1,500;1,600;1,700&display=swap" rel="stylesheet">

Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma

Yıl: 2021 Cilt: 5 Sayı: 2 Sayfa Aralığı: 256 - 262 Metin Dili: İngilizce DOI: 10.14744/ejmo.2021.74738 İndeks Tarihi: 26-01-2022

Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma

Öz:
Objectives: Prognostic nutritional index (PNI) is an inflammation-based score which was found to be predictive ofsurvival for different types of cancer. Aim of present study is to investigate the association between PNI and survivaloutcomes in patients with soft tissue sarcoma (STS) operated with curative intent. Methods: We retrospectively collected data of 86 patients with localized STS. Preoperative PNI was calculated with thefollowing formula:10×serum albumin (g/dL)+0.005×total lymphocyte count (per mm3 ). Patients were classified into 2groups based on median PNI value. Results: Median age was 52.5 (18-86) years. There were 49 male and 37 female patients. Most common histology wasliposarcoma (26.7%). Our cohort mainly included stage 3 (69.8%) and grade 3 (66.3%) tumors. Radiotherapy and chemotherapy were applied to 69.8% and 48.8% of patients, respectively. Median value of PNI was 48.2 (25.5-68.0). Medianfollow-up duration was 25 months (3-120). Median overall survival (OS) was 84.6 months (95% CI, 72.0-97.3). MedianOS of patients with high PNI (≥48.2) was significantly longer than patients with low PNI (<48.2), being 99.6 months(95%CI, 83.6-115.6) and 64.5 months(95% CI, 50.3-78.7), respectively(p=0.02). Multivariate analysis determined PNI as anindependent prognostic indicator for OS [HR: 2.96, (95% CI 1.11–7.87), p=0.02] along with age. Conclusion: Our findings suggest that PNI predicts OS independently in patients with STS. Therefore, PNI is a valuableprognostic tool in preoperative setting.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • 1. Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin Sarcoma Res 2012;2:14.
  • 2. Lindberg RD, Martin RG, Romsdahl MM, Barkley HT Jr. Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas. Cancer 1981;47:2391–7.
  • 3. Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol 2003;21:2719–25.
  • 4. NIH. SEER Stat Fact Sheets: Soft Tissue Including Heart. National Cancer Institute, Surveillance Epidemiology and End Results. Available on: http://seer.cancer.gov/statfacts/html/ soft.html (Accessed December 19, 2020).
  • 5. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013;13:759–71.
  • 6. Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma. J Surg Oncol 2013;108:481–5.
  • 7. Liang Y, Xiao W, Guan YX, Wang W, Chen HY, Fang C, et al. Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma. Oncotarget 2017;8:98135–47.
  • 8. Fang E, Wang X, Feng J, Zhao X. The prognostic role of Glasgow Prognostic Score and C-reactive protein to albumin ratio for sarcoma: a system review and meta-analysis. Dis Markers 2020;2020:8736509.
  • 9. Maretty-Kongstad K, Aggerholm-Pedersen N, Keller J, Safwat A. A validated prognostic biomarker score for adult patients with nonmetastatic soft tissue sarcomas of the trunk and extremities. Transl Oncol 2017;10:942–8.
  • 10. Liang Y, Wang W, Que Y, Guan Y, Xiao W, Fang C, et al. Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma. BMC Cancer 2018;18942.
  • 11. Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 1984;85:1001–5. [Article in Japanese]
  • 12. Li D, Yuan X, Liu J, Li C, Li W. Prognostic value of prognostic nutritional index in lung cancer: a meta-analysis. J Thorac Dis 2018;10:5298–307.
  • 13. Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, Fukumoto Y, et al. Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients. Langenbecks Arch Surg 2017;402:501–7.
  • 14. Peng D, Gong YQ, Hao H, He ZS, Li XS, Zhang CJ, et al. Preoperative prognostic nutritional index is a significant predictor of survival with bladder cancer after radical cystectomy: a retrospective study. BMC Cancer 2017;17:391.
  • 15. Zhang W, Ye B, Liang W, Ren Y. Preoperative prognostic nutritional index is a powerful predictor of prognosis in patients with stage III ovarian cancer. Sci Rep 2017;7:9548.
  • 16. Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M. Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg 2013;37:2688–92.
  • 17. Kim TWB, Hardy S, Pericic DJ, Gaughan J, Angelo M. Onodera’s Prognostic Nutritional Index in soft tissue sarcoma patients as a predictor of wound complications. Journal of Communıty and Supportıve Oncology 2017;15:204–7.
  • 18. Amin MB, Edge S, Greene F. AJCC Cancer Staging Manual. 8th ed. Cham, Switzterland: Springer International Publishing, 2017.
  • 19. Neuville A, Chibon F, Coindre JM. Grading of soft tissue sarcomas: from histological to molecular assessment. Pathology 2014;46:113–20.
  • 20. Korniluk A, Koper O, Kemona H, Dymicka-Piekarska V. From inflammation to cancer. Ir J Med Sci 2017;186:57–62.
  • 21. Balkwill FR, Mantovani A. Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 2012;22:33–40.
  • 22. Gomes de Lima KV, Maio R. Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer. Nutr Hosp 2012;27:707–14.
  • 23. Deans DA, Tan BH, Wigmore SJ, Ross JA, de Beaux AC, PatersonBrown S, et al. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 2009;100:63–9.
  • 24. Laviano A, Meguid MM, Preziosa I, Rossi Fanelli F. Oxidative stress and wasting in cancer. Curr Opin Clin Nutr Metab Care 2007;10:449–56.
  • 25. Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 2010;9:69.
  • 26. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883–99.
  • 27. Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, et al; European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 2009;69:5383–91.
APA TELLİ T, SARIYER N, Alan O, Demircan N, ışık s, ARIKAN R, BAŞOĞLU T, YAŞAR A, çelebi a, SOFULLU Ö, EROL B, TÜRKÖZ H, ÖZGEN Z, ERCELEP Ö, Dane F, YUMUK P (2021). Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma. , 256 - 262. 10.14744/ejmo.2021.74738
Chicago TELLİ Tuğba AKIN,SARIYER Nisanur,Alan Ozkan,Demircan Nazım Can,ışık selver,ARIKAN Rukiye,BAŞOĞLU Tuğba,YAŞAR Alper,çelebi abdussamet,SOFULLU Ömer,EROL Bülent,TÜRKÖZ Hüseyin Kemal,ÖZGEN Zerrin,ERCELEP Özlem,Dane Faysal,YUMUK Perran Fulden Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma. (2021): 256 - 262. 10.14744/ejmo.2021.74738
MLA TELLİ Tuğba AKIN,SARIYER Nisanur,Alan Ozkan,Demircan Nazım Can,ışık selver,ARIKAN Rukiye,BAŞOĞLU Tuğba,YAŞAR Alper,çelebi abdussamet,SOFULLU Ömer,EROL Bülent,TÜRKÖZ Hüseyin Kemal,ÖZGEN Zerrin,ERCELEP Özlem,Dane Faysal,YUMUK Perran Fulden Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma. , 2021, ss.256 - 262. 10.14744/ejmo.2021.74738
AMA TELLİ T,SARIYER N,Alan O,Demircan N,ışık s,ARIKAN R,BAŞOĞLU T,YAŞAR A,çelebi a,SOFULLU Ö,EROL B,TÜRKÖZ H,ÖZGEN Z,ERCELEP Ö,Dane F,YUMUK P Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma. . 2021; 256 - 262. 10.14744/ejmo.2021.74738
Vancouver TELLİ T,SARIYER N,Alan O,Demircan N,ışık s,ARIKAN R,BAŞOĞLU T,YAŞAR A,çelebi a,SOFULLU Ö,EROL B,TÜRKÖZ H,ÖZGEN Z,ERCELEP Ö,Dane F,YUMUK P Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma. . 2021; 256 - 262. 10.14744/ejmo.2021.74738
IEEE TELLİ T,SARIYER N,Alan O,Demircan N,ışık s,ARIKAN R,BAŞOĞLU T,YAŞAR A,çelebi a,SOFULLU Ö,EROL B,TÜRKÖZ H,ÖZGEN Z,ERCELEP Ö,Dane F,YUMUK P "Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma." , ss.256 - 262, 2021. 10.14744/ejmo.2021.74738
ISNAD TELLİ, Tuğba AKIN vd. "Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma". (2021), 256-262. https://doi.org/10.14744/ejmo.2021.74738
APA TELLİ T, SARIYER N, Alan O, Demircan N, ışık s, ARIKAN R, BAŞOĞLU T, YAŞAR A, çelebi a, SOFULLU Ö, EROL B, TÜRKÖZ H, ÖZGEN Z, ERCELEP Ö, Dane F, YUMUK P (2021). Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma. Eurasian Journal of Medical Investigation, 5(2), 256 - 262. 10.14744/ejmo.2021.74738
Chicago TELLİ Tuğba AKIN,SARIYER Nisanur,Alan Ozkan,Demircan Nazım Can,ışık selver,ARIKAN Rukiye,BAŞOĞLU Tuğba,YAŞAR Alper,çelebi abdussamet,SOFULLU Ömer,EROL Bülent,TÜRKÖZ Hüseyin Kemal,ÖZGEN Zerrin,ERCELEP Özlem,Dane Faysal,YUMUK Perran Fulden Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma. Eurasian Journal of Medical Investigation 5, no.2 (2021): 256 - 262. 10.14744/ejmo.2021.74738
MLA TELLİ Tuğba AKIN,SARIYER Nisanur,Alan Ozkan,Demircan Nazım Can,ışık selver,ARIKAN Rukiye,BAŞOĞLU Tuğba,YAŞAR Alper,çelebi abdussamet,SOFULLU Ömer,EROL Bülent,TÜRKÖZ Hüseyin Kemal,ÖZGEN Zerrin,ERCELEP Özlem,Dane Faysal,YUMUK Perran Fulden Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma. Eurasian Journal of Medical Investigation, vol.5, no.2, 2021, ss.256 - 262. 10.14744/ejmo.2021.74738
AMA TELLİ T,SARIYER N,Alan O,Demircan N,ışık s,ARIKAN R,BAŞOĞLU T,YAŞAR A,çelebi a,SOFULLU Ö,EROL B,TÜRKÖZ H,ÖZGEN Z,ERCELEP Ö,Dane F,YUMUK P Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma. Eurasian Journal of Medical Investigation. 2021; 5(2): 256 - 262. 10.14744/ejmo.2021.74738
Vancouver TELLİ T,SARIYER N,Alan O,Demircan N,ışık s,ARIKAN R,BAŞOĞLU T,YAŞAR A,çelebi a,SOFULLU Ö,EROL B,TÜRKÖZ H,ÖZGEN Z,ERCELEP Ö,Dane F,YUMUK P Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma. Eurasian Journal of Medical Investigation. 2021; 5(2): 256 - 262. 10.14744/ejmo.2021.74738
IEEE TELLİ T,SARIYER N,Alan O,Demircan N,ışık s,ARIKAN R,BAŞOĞLU T,YAŞAR A,çelebi a,SOFULLU Ö,EROL B,TÜRKÖZ H,ÖZGEN Z,ERCELEP Ö,Dane F,YUMUK P "Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma." Eurasian Journal of Medical Investigation, 5, ss.256 - 262, 2021. 10.14744/ejmo.2021.74738
ISNAD TELLİ, Tuğba AKIN vd. "Preoperative Prognostic Nutritional Index is a Strong Predictorof Survival in Patients with Localized Soft Tissue Sarcoma". Eurasian Journal of Medical Investigation 5/2 (2021), 256-262. https://doi.org/10.14744/ejmo.2021.74738